Safety and usefulness of endoscopic submucosal dissection for early esophageal cancers in elderly patients aged 80 years or older.
Elderly patient
Endoscopic submucosal dissection
Esophageal cancer
Journal
Esophagus : official journal of the Japan Esophageal Society
ISSN: 1612-9067
Titre abrégé: Esophagus
Pays: Japan
ID NLM: 101206627
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
03
03
2020
accepted:
19
05
2020
pubmed:
31
5
2020
medline:
26
3
2022
entrez:
31
5
2020
Statut:
ppublish
Résumé
Endoscopic submucosal dissection (ESD) for early gastrointestinal (GI) cancers is widely performed as a standard treatment in Japan. Given the increasing life expectancy worldwide, it is naturally regarded that the rate of elderly patients diagnosed with early GI cancer has increased. Available guidelines do not specifically outline how to manage endoscopic therapy for the elderly. The aim of this study was to assess the safety and usefulness of ESD for superficial esophageal squamous cell carcinoma (SESCC) in elderly patients. We retrospectively investigated 393 consecutive patients, who underwent 426 ESD for 444 SESCCs from January 2011 to August 2016 at our institution. For this study, patients were divided into 2 groups based on their age; ≥ 80 years (Group aged ≥ 80 years, n = 42) and < 80 years (group aged < 80 years, n = 351). Patient demographics, sedation methods, technical outcomes, adverse events, sedatives, dosages given, overall survival, and disease-specific survival were then examined. The ESD procedure time was significantly longer for group aged ≥ 80 years than for group aged < 80 years (110 min [range 29-260] vs 85 min [24-504], p = 0.006); however, there was no significant differences between other technical items and adverse events. The 3-year overall survival and disease-specific survival were favorable in both groups. Esophageal ESD for elderly patients aged ≥ 80 years can be safely performed. Mid-term outcome was favorable. Our study suggests that esophageal ESD might be a useful treatment for SESCCs.
Sections du résumé
BACKGROUND AND AIM
Endoscopic submucosal dissection (ESD) for early gastrointestinal (GI) cancers is widely performed as a standard treatment in Japan. Given the increasing life expectancy worldwide, it is naturally regarded that the rate of elderly patients diagnosed with early GI cancer has increased. Available guidelines do not specifically outline how to manage endoscopic therapy for the elderly. The aim of this study was to assess the safety and usefulness of ESD for superficial esophageal squamous cell carcinoma (SESCC) in elderly patients.
METHODS
We retrospectively investigated 393 consecutive patients, who underwent 426 ESD for 444 SESCCs from January 2011 to August 2016 at our institution. For this study, patients were divided into 2 groups based on their age; ≥ 80 years (Group aged ≥ 80 years, n = 42) and < 80 years (group aged < 80 years, n = 351). Patient demographics, sedation methods, technical outcomes, adverse events, sedatives, dosages given, overall survival, and disease-specific survival were then examined.
RESULTS
The ESD procedure time was significantly longer for group aged ≥ 80 years than for group aged < 80 years (110 min [range 29-260] vs 85 min [24-504], p = 0.006); however, there was no significant differences between other technical items and adverse events. The 3-year overall survival and disease-specific survival were favorable in both groups.
CONCLUSIONS
Esophageal ESD for elderly patients aged ≥ 80 years can be safely performed. Mid-term outcome was favorable. Our study suggests that esophageal ESD might be a useful treatment for SESCCs.
Identifiants
pubmed: 32472275
doi: 10.1007/s10388-020-00750-9
pii: 10.1007/s10388-020-00750-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
81-89Références
Gotoda T, Iwasaki M, Kusano C, et al. Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria. Br J Surg. 2010;97:868–71.
doi: 10.1002/bjs.7033
Oda I, Gotoda T, Hamanaka H, et al. Endoscopic submucosal dissection for early gastric cancer: technical feasibility, operation time and complications from a large consecutive series. Dig Endosc. 2005;17:54–8.
doi: 10.1111/j.1443-1661.2005.00459.x
Fujishiro M, Kodashima S, Goto O, et al. Endoscopic submucosal dissection for esophageal squamous cell neoplasms. Dig Endosc. 2009;21:109–15.
doi: 10.1111/j.1443-1661.2009.00837.x
Saito Y, Kawano H, Takeuchi Y, et al. Current status of colorectal endoscopic submucosal dissection in Japan and other Asian countries: Progressing towards technical standardization. Dig Endosc. 2012;24:67–72.
doi: 10.1111/j.1443-1661.2012.01282.x
Gotoda T. Endoscopic resection of early gastric cancer. Gastric Cancer. 2007;10:1–11.
doi: 10.1007/s10120-006-0408-1
Nonaka S, Oda I, Nakaya T, et al. Clinical impact of a strategy involving endoscopic submucosal dissection for early gastric cancer: determining the optimal pathway. Gastric Cancer. 2011;14:56–62.
doi: 10.1007/s10120-011-0008-6
Ishihara R, Ishii H, Uedo N, et al. Comparison of EMR and endoscopic submucosal dissection for en bloc resection of early esophageal cancers in Japan. Gastrointest Endosc. 2008;68:1066–72.
doi: 10.1016/j.gie.2008.03.1114
Fonkalsrud L, Hwang JH, Khashab MA, et al. Guidelines for sedation and anesthesia in GI endoscopy. Gastrointest Endosc. 2018;87:327–37.
doi: 10.1016/j.gie.2017.07.018
Evans JA, Early DS, Chandraskhara V, et al. The role of endoscopy in the assessment and treatment of esophageal cancer. Gastrointest Endosc. 2013;77:328–44.
doi: 10.1016/j.gie.2012.10.001
Dumonceau JM, Riphaus A, Beilenhoff U, et al. European curriculum for sedation training in gastrointestinal endoscopy: position statement of the European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA). Endoscopy. 2013;45:496–504.
doi: 10.1055/s-0033-1344142
Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T, et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2015;47:829–54.
doi: 10.1055/s-0034-1392882
Early DS, Lightdale JR, Vargo JJ, et al. Guidelines for sedation and anesthesia in GI endoscopy. Gastrointest Endosc. 2018;87:327–37.
doi: 10.1016/j.gie.2017.07.018
Sekiguchi M, Oda I, Suzuki H, et al. Clinical outcomes and prognostic factors ingastric cancer patients aged ≥ 85 years undergoing endoscopic submucosal dissection. Gastrointest Endosc. 2017;85:963–72.
doi: 10.1016/j.gie.2016.10.013
Higuchi K, Tanabe S, Azuma M, et al. A phase II study of endoscopic submucosal dissection for superficial esophageal neoplasms (KDOG0901). Gastrointest Endosc. 2013;78:704–10.
doi: 10.1016/j.gie.2013.04.182
Ono S, Fujishiro M, Niimi K, et al. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc. 2009;70:860–6.
doi: 10.1016/j.gie.2009.04.044
Vargo JJ, DeLegge MH, Feld AD, et al. Multisociety sedation curriculum for gastrointestinal endoscopy. American Association for Study of Liver Diseases; American College of Gastroenterology; American Gastroenterological Association Institute; American Society for Gastrointestinal Endoscopy; Society for Gastroenterology Nurses and Associates. Gastrointest Endosc. 2012;76:e1–25.
doi: 10.1016/j.gie.2012.03.001
Japan Esophageal Society. Japanese classification of esophageal cancer, 11th edition: Part I. Esophagus. 2017;14:1–36.
doi: 10.1007/s10388-016-0551-7
Japan Esophageal Society. Japanese classification of esophageal cancer, 11th edition: Part II and III. Esophagus. 2017;14:37–65.
doi: 10.1007/s10388-016-0556-2
Kuwano H, Nishimura Y, Oyama T, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2015;12:1–30.
doi: 10.1007/s10388-014-0465-1
Shimizu Y, Takahashi M, Yoshida T, et al. Endoscopic resection (endoscopic mucosal resection/ endoscopic submucosal dissection) for superficial esophageal squamous cell carcinoma: current status of various techniques. Dig Endosc. 2013;25:13–9.
doi: 10.1111/j.1443-1661.2012.01408.x
Gambus PL, Jensen EW, Jospin M, et al. Modeling the effect of propofol and remifentanil combinations for sedation-analgesia in endoscopic procedures using an adaptive neuro fuzzy inference system (ANFIS). Anesth Analg. 2011;112:331–9.
doi: 10.1213/ANE.0b013e3182025a70
Gillham MJ, Hutchinson RC, Carter R, et al. Patient-maintained sedation for ERCP with a target-controlled infusion of propofol: a pilot study. Gastrointest Endosc. 2001;54:14–7.
doi: 10.1067/mge.2001.116358
Peng C, Shen S, Xu G, et al. Efficacy and Safety of endoscopic submucosal dissection for elderly patients with superficial squamous esophageal neoplasms. United Eur Gastroenterol J. 2016;4:242–9.
doi: 10.1177/2050640615604780
Song BG, Min YW, Lee JH, et al. Efficacy and Safety of endoscopic submucosal dissection in elderly patients with esophageal squamous cell carcinoma. Surg Endosc. 2017;31:3905–11.
doi: 10.1007/s00464-017-5421-4
Noh JH, Gong EJ, Kim DH et al. Endoscopic Submucosal dissection for superficial esophageal neoplasms in elderly patients: a single-center, large-scale, retrospective study. Geriatr Gerontol Int. 2020, pp. 1–6 (online ahead of print).
Horiuchi A, Nakayama Y, Tanaka N, et al. Propofol sedation for endoscopic procedures in patients 90 years of age and older. Digestion. 2008;78:20–3.
doi: 10.1159/000151765
Jopling MW, Qiu J. Capnography sensor use is associated with reduction of adverse outcomes during gastrointestinal endoscopic procedures with sedation administration. BMC Anesthesiol. 2017;17:157.
doi: 10.1186/s12871-017-0453-9
Sasaki T, Tanabe S, Azuma M, et al. Propofol sedation with bispectral index monitoring is useful for endoscopic submucosal dissection: a randomized prospective phase II clinical trial. Endoscopy. 2012;44:584–9.
doi: 10.1055/s-0032-1306776
Nakajo I, Abe K, Oda S, et al. Impact of the Charlson Comorbidity Index on the treatment strategy and survival in elderly patients after non-curative endoscopic submucosal dissection for esophageal squamous cell carcinoma: a multicenter retrospective study. J Gastroenterol. 2019;54:871–80.
doi: 10.1007/s00535-019-01583-9
Onochi K, Shiga H, Takahashi S, et al. Risk factors linking esophageal squamous cell carcinoma with head and neck cancer or gastric cancer. J Clin Gastroenterol. 2019;53:e164–e170170.
doi: 10.1097/MCG.0000000000001019